Research Developments in Atopic Dermatitis

Erfahren Sie die neuesten Erkenntnisse zur atopischen Dermatitis aus den virtuellen Sitzungen von 2020, mit Expertenmeinungen zu innovativen Therapien und deren klinischen Auswirkungen.

Neueste Folgen

Sep 8, 2020

Introduction and Overview

S1 E1 • 5 mins

Sep 8, 2020

Efficacy and Safety Trends with Continuous Longterm Use of Crisaborole Ointment 2% in Patients with Mild-to-Moderate Atopic Dermatitis

S1 E2 • 7 mins

Sep 8, 2020

Safety, Efficacy and Pharmacokinetics of Crisaborole Ointment 2% in Infants Age Three to Less Than 24 Months with Mild-to-Moderate Atopic Dermatitis

S1 E3 • 7 mins

Sep 8, 2020

Association Between an Itch-Free State in Atopic Dermatitis Treated with Ruxolitinib Cream and Systemic Inflammatory Mediators

S1 E4 • 5 mins

Sep 8, 2020

Dupilumab Treatment for up to Three Years Demonstrates Sustained Efficacy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Liberty AD Adult Open Label Extension

S1 E5 • 5 mins